Expertise in
8
conditions

Dr. Sureyya Savasan

Hematology | Oncology
DMC Children's Hospital Of Michigan
3901 Beaubien St, 
Detroit, MI 
Accepting New Patients
Expertise in
8
conditions
DMC Children's Hospital Of Michigan
3901 Beaubien St, 
Detroit, MI 

Overview

Sureyya Savasan is a Hematologist and an Oncologist practicing medicine in Detroit, Michigan.

Dr. Savasan is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Evans Syndrome, Anemia, Leukemia, Bone Marrow Transplant, and Bone Marrow Aspiration.

He is actively involved in clinical research, co-authoring 80 peer reviewed articles and participating in 4 clinical trials. Dr. Savasan is currently accepting new patients.

Specialties

Hematology
Oncology

Licenses

Pediatrics in MI

Languages Spoken

English
Turkish

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
McLaren Health
  • HMO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Priority Health
  • HMO
  • POS
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 5 Less Insurance Carriers -

Locations

DMC Children's Hospital of Michigan
3901 Beaubien St, Detroit, MI 48201

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Randomized Phase 3 Study of Brentuximab Vedotin (SGN-35) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Young Adults
A Randomized Phase 3 Study of Brentuximab Vedotin (SGN-35) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Young Adults
Enrollment Status: Active_not_recruiting
Publish Date: July 29, 2026
Intervention Type: Other, Drug, Biological
Study Drugs: Bleomycin, Brentuximab, Cyclophosphamide, Doxorubicin, Etoposide, Methylprednisolone, Prednisone, Vincristine
Study Phase: Phase 3
Renal Tumors Classification, Biology, and Banking Study
Renal Tumors Classification, Biology, and Banking Study
Enrollment Status: Completed
Publish Date: May 18, 2026
Intervention Type: Other
Applying Biomarkers to Long-term Effects in Child and Adolescent Cancer Treatment (ABLE Team) - Predictive Biomarkers For Pediatric Chronic Graft-Versus-Host Disease
Applying Biomarkers to Long-term Effects in Child and Adolescent Cancer Treatment (ABLE Team) - Predictive Biomarkers For Pediatric Chronic Graft-Versus-Host Disease
Enrollment Status: Unknown
Publish Date: December 05, 2023
A Phase 3, Randomized, Adaptive Study Comparing the Efficacy and Safety of Defibrotide vs Best Supportive Care in the Prevention of Hepatic Veno-Occlusive Disease in Adult and Pediatric Patients Undergoing Hematopoietic Stem Cell Transplant
A Phase 3, Randomized, Adaptive Study Comparing the Efficacy and Safety of Defibrotide vs Best Supportive Care in the Prevention of Hepatic Veno-Occlusive Disease in Adult and Pediatric Patients Undergoing Hematopoietic Stem Cell Transplant
Enrollment Status: Completed
Publish Date: March 02, 2022
Intervention Type: Other, Drug
Study Phase: Phase 3
View 3 Less Clinical Trials

80 Total Publications

Case Report: Primary hemophagocytic lymphohistiocytosis with a homozygous PRF1 variant: a case suggesting early immunoporosis and an expanded phenotypic spectrum.
Case Report: Primary hemophagocytic lymphohistiocytosis with a homozygous PRF1 variant: a case suggesting early immunoporosis and an expanded phenotypic spectrum.
Journal: Frontiers in immunology
Published: May 07, 2026
Similar Doctors
Expertise in
8
conditions
Dr. Michael U. Callaghan
Hematology | Oncology
Expertise in
8
conditions
Dr. Michael U. Callaghan
Hematology | Oncology
Referral may be required

DMC Children's Hospital Of Michigan

3901 Beaubien St, 
Detroit, MI 
 (0.1 miles away)
313-745-5515
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Michael Callaghan is a Hematologist and an Oncologist practicing medicine in Detroit, Michigan. Dr. Callaghan is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Hemophilia A, Blood Clots, Sickle Cell Disease, Evans Syndrome, and Splenectomy. Dr. Callaghan is currently accepting new patients.

Expertise in
5
conditions
Dr. Meera B. Chitlur
Hematology | Oncology
Expertise in
5
conditions
Dr. Meera B. Chitlur
Hematology | Oncology
Referral may be required

DMC Children's Hospital Of Michigan

3901 Beaubien St, 
Detroit, MI 
 (0.1 miles away)
313-745-5515
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Meera Chitlur is a Hematologist and an Oncologist practicing medicine in Detroit, Michigan. Dr. Chitlur is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses Glanzmann Thrombasthenia, Blood Clots, Hemophilia A, and Evans Syndrome. Dr. Chitlur is currently accepting new patients.

Expertise in
35
conditions
Dr. Rajen J. Mody
Hematology | Oncology
Expertise in
35
conditions
Dr. Rajen J. Mody
Hematology | Oncology
Referral may be required

University Of Michigan Medical Center

1500 E Medical Center Dr, 
Ann Arbor, MI 
 (34.7 miles away)
734-936-9814
Languages Spoken:
English, Hindi
See accepted insurances
Accepting New Patients

Rajen Mody is a Hematologist and an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Mody is highly rated in 35 conditions, according to our data. His clinical expertise encompasses Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Gliomatosis Cerebri, Neuroepithelioma, and Bone Marrow Aspiration. Dr. Mody is currently accepting new patients.

Frequently Asked Questions about Dr. Sureyya Savasan

How do I make an appointment with Dr. Sureyya Savasan?

You can book an appointment with Dr. Sureyya Savasan by calling their office at 313-745-5515. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Sureyya Savasan a top-rated expert for Evans Syndrome?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Sureyya Savasan is classified as an Advanced expert for Evans Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Sureyya Savasan specialize in?

While Dr. Sureyya Savasan is a Hematology, they have specific expertise in Evans Syndrome, Anemia, and Bone Marrow Transplant. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Sureyya Savasan participate in research or clinical trials?

Yes. Dr. Sureyya Savasan has published 80 articles and abstracts on conditions like Evans Syndrome. You can view a list of Dr. Sureyya Savasan's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Sureyya Savasan accept my insurance?

Dr. Sureyya Savasan accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 313-745-5515 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Savasan's expertise for a condition
ConditionClose
      View All 8 Advanced Conditions
      View All 42 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile